CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-01 | Hassanein Waleed H President & CEO | Sale | −5,546 | $71.44 | $396K | 553,645 |
| 2023-06-01 | Hassanein Waleed H President & CEO | Sale | −1,954 | $72.21 | $141K | 551,691 |
| 2023-05-25 | KANIA EDWIN M JR Director | Grant or award | +1,193 | 257,944 | ||
| 2023-05-25 | KANIA EDWIN M JR Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-25 | TOBIN JAMES R Director | Grant or award | +1,193 | 1,193 | ||
| 2023-05-25 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-25 | RAINES MERILEE Director | Grant or award | +1,193 | 1,193 | ||
| 2023-05-25 | RAINES MERILEE Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-25 | Gunderson Thomas James Director | Grant or award | +1,193 | 1,193 | ||
| 2023-05-25 | Gunderson Thomas James Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-25 | Basile Edward M Director | Grant or award | +1,193 | 15,507 | ||
| 2023-05-25 | Basile Edward M Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-25 | Weill David Director | Grant or award | +1,193 | 11,193 | ||
| 2023-05-25 | Weill David Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-25 | Lovell Stephanie Director | Grant or award | +1,193 | 1,193 | ||
| 2023-05-25 | Lovell Stephanie Director | Grant or award · Stock Option (Right to Buy) | +1,916 | 1,916 | ||
| 2023-05-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +5,000 | $16.14 | $81K | 23,789 |
| 2023-05-01 | Gordon Stephen Chief Financial Officer | Sale | −5,000 | $79.05 | $395K | 18,789 |
| 2023-05-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 10,728 | ||
| 2023-05-01 | Hassanein Waleed H President & CEO | Sale | −5,406 | $77.84 | $421K | 561,285 |
Page 25 of 38 · 744 trades